Showing posts with label Hypercholesterolemia. Show all posts
Showing posts with label Hypercholesterolemia. Show all posts

Why So Many Cases Of Familial Hypercholesterolemia Go Undiagnosed And How To Avoid The Same Fate

Familial hypercholesterolemia can be genetically inherited from either parent and is an autosomal dominant genetic disorder. The gene mutation is located on chromosome 19 and gives any parent with the disorder a 50% chance of passing it on to one or more of his or her children. If both parents have it, their children will definitely inherit the disorder to varying degrees. Every year, we learn more about this disorder, which occurs worldwide in approximately one in every five hundred individuals. It is estimated, however, that as much as 80% of people with familial hypercholesterolemia go undiagnosed and untreated. But if researchers are learning so much about this familial disorder that can lead to cardiac disease and heart attack, why is it missed so often in the United States and other countries?

Cholesterol Testing Limited To At-Risk Adults

Because children and young adults rarely have high cholesterol levels, testing for the build-up of fatty deposits in the bloodstream and abnormally elevated cholesterol levels aren't usually done unless there are other, physical symptoms that lead doctors to request laboratory tests. Unfortunately, in some cases the long-term effects of the disease can cause a heart attack or cardiac episode, sometimes ending in death, before the individual is diagnosed with the disorder. It isn't effective or necessary to test children at a young age unless they meet other criteria that could indicate a cardiac condition or a predisposition toward heart attacks, including a family history of early cardiac abnormalities.

Families Don't Connect Heart Attacks To Familial Hypercholesterolemia

Many individuals today have experienced the loss of a loved one to an early heart attack or coronary artery disease and its complications. Most of these people don't, however, connect heart attacks in adults with the possibility that there could be an inherited disorder that manifests itself in any significant way in their children. They assume that they don't have to start worrying until they are in their 30s or 40s at the earliest. You may have heard someone say they are "destined to have a heart attack, just like my Dad," yet these same individuals don't understand that the foundation for such a cardiac event may have roots in their childhood and that these childhood conditions can be improved in order to minimize risk.

Increased Awareness Means Earlier Diagnosis

Fortunately, more people are being diagnosed earlier in life than ever before, largely due to an increased awareness of the disease. More physicians are asking the right questions and taking the time to track genetic links between their patients and the early cardiac problems of their patients' parents and grandparents. They are also more aware of the early symptoms, which may seem innocuous on the surface but are often the earliest indications of a problem. When familial hypercholesterolemia is suspected, genetic testing is often ordered, which focuses on mutations in the nineteenth chromosome. Once a diagnosis is positive, other family members can be tested and treated as early as age two.

Become Part Of The 20%

If you want to make sure you aren't one of the 80% of undiagnosed cases of familial hypercholesterolemia, learn what the warning signs are and be vigilant about bringing them to the attention of your regular physician so that he or she can be proactive in a treatment approach. Some warning signs include:

• A family history of heart disease, particularly if men in their 40s or women in their 50s have had cardiac incidences in the past.

• Watch for warning signs in family members of all ages. Early symptoms can include fatty deposits under the skin, particularly around the eyes. These are fatty deposits called xanthelasmata.

• Swollen tendons around the heel or on the backs of the hands can result in a bloated or swollen appearance. These puffy areas are referred to as xanthoma.

• A narrow, white ring at the edge of the pupil or iris of the eye, called arcus cornealis, is often seen in younger individuals who have familial hypercholesterolemia.

• Taking drugs to lower your cholesterol, watching your weight and exercising without any noticeable change in your blood work.

If you or someone you love has any of these early warning signs, talk to your doctor about having the rest of your family checked and the possibility of genetic testing so that proper treatment can be administered right away so that you and your children can avoid the fate of many undiagnosed patients who later succumbed to a heart attack or other cardiac problems.

The FH Foundation is a leader in educating individuals about the dangers of and treatments for familial hypercholesterolemia. If your family has a history of early heart disease, visit the FH Foundation website to learn more about this disease.

Treatment Options For Homozygous Familial Hypercholesterolemia Are Varied And Sometimes Difficult

Homozygous familial hypercholesterolemia is an extremely severe and rare form of hypercholesterolemia that strikes only about one in one million individuals. There may be less than one million people in the world who currently have this disease, but those who do usually have to try a variety of therapies to keep their cholesterol levels under control. If you have this rare condition, your body's LDL receptors may not function at all or function at a severely curtailed level. There are several available treatment options, and most individuals will have to try a combination for the best results.

Moderate Success With Some Medications

Treating Homozygous FH with medication or a combination of medications is usually the first option tried by doctors treating patients with this severe form of familial hypercholesterolemia. The most successful is usually a combination of cholesterol absorption inhibitors and very high doses of statin drugs. While this is successful in some adults and children, it should be noted that these drugs need to be carefully monitored, particularly when given to children who may not tolerate the high dosages as well as adults. To improve results, patients should also exercise regularly and stick to a low cholesterol diet.

Drastic Treatment Options When Medication Isn't Enough

Unfortunately, there are some individuals with homozygous familial hypercholesterolemia who don't respond well to medications either alone or in combination. In these severe cases, other treatments may be required, including apheresis, a process similar to kidney dialysis that filters cholesterol from the bloodstream. Liver transplants are also an option, particularly for patients who have to undergo apheresis on a frequent basis. Another surgical procedure is partial ileal bypass surgery, in which a portion of the small bowel is bypassed in order to decrease the absorption of certain nutrients. Either of these surgical options can also be combined with diet, exercise and some medications in order to improve the ongoing odds of controlling your cholesterol levels and preventing the onset of heart disease.

Recent Developments In Treatment Of Homozygous Familial Hypercholesterolemia

On December 24, 2012, the Food and Drug Administration (FDA) approved a new drug called Lomitapide for patients suffering from homozygous familial hypercholesterolemia who have not responded well to other therapies or are limited in their treatment options. Careful monitoring of patients will be needed, as there is the potential for liver toxicity over time. Questions still remain regarding its efficacy and safety for use in children and clinical trials will continue in order to gain a greater understanding of its potential advantages.

Because homozygous familial hypercholesterolemia is usually extremely severe, with cholesterol levels that can be off the charts, it's critical thata variety of treatment options are tried in order to find the combination that works best for you. Consulting with a physician who is familiar with this disease and its various treatment options is extremely important. There are also support groups and non-profit organizations where you can register for clinical trials and learn more about the latest options in controlling cholesterol levels.

The FH Foundation was founded to help families cope with heterozygous and homozygous familial hypercholesterolemia and the impact of FH on their lives. They are advocates of education, research and proactive treatment to improve the quality of life for FH families. For more information, visit the FH Foundation website.